Brain Metastasis-A Distinct Oncologic Disease Best Served by an Integrated Multidisciplinary Team Approach

Affiliations

¹ Department of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, New York.
² Department of Radiation Oncology and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, New York.

Nelson S Moss et al. JAMA Oncol. 2022.

. 2022 Sep 1;8(9):1252-1254.

doi: 10.1001/jamaoncol.2022.1928.

¹ Department of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, New York.
² Department of Radiation Oncology and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, New York.

No abstract available

References

1. FDA In Brief: FDA Works to Evaluate Cancer Therapies in Patients with Brain Metastases. Published online August 26, 2020. Accessed March 2, 2022. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-works-evaluate-c...
1. Tawbi HA, Forsyth PA, Hodi FS, et al. Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204). Neuro-Oncology. 2021;23(11):1961–1973. doi:10.1093/neuonc/noab094 - DOI - PMC - PubMed
1. Kesson EM, Allardice GM, George WD, Burns HJG, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012;344(apr26 1):e2718–e2718. doi:10.1136/bmj.e2718 - DOI - PMC - PubMed
1. Loh D, Hogg F, Edwards P, et al. Two-year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre. British Journal of Neurosurgery. 2018;32(1):53–60. doi:10.1080/02688697.2017.1368449 - DOI - PubMed
1. McKee MJ, Keith K, Deal AM, et al. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience. The Oncologist. 2016;21(1):16–20. doi:10.1634/theoncologist.2015-0328 - DOI - PMC - PubMed